Welcome : Guest

Chembio Diagnostics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Chembio Diagnostics, Inc., which is principally involved in providing Rapid Point-of-Care Diagnostic Tests. Illustrated with 37 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-64017
Price: $1850
Company Type: Public
Pages: 39
Date: November 2016
Market Data Tables: 37

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Chembio Diagnostics, Inc.’s Sales by Product Category Worldwide (2014-2015) in Percentage for Lateral Flow HIV Tests and Components, DPP® Tests and Components, Others, License and Royalty Revenue, and R&D, Milestone and Grant Revenue......3
Table 2: Chembio Diagnostics, Inc.’s (Operations) Sales by Geographic Region Worldwide (2015) in Percentage for Africa, Asia, Europe, North America, and South America......4
Molecular Diagnostics......5
Table 3: Molecular Diagnostics Market by Application Worldwide (2015) - Percentage Share Breakdown by Value for Blood Screening, Genetics, Infectious Disease, Oncology and Others......5
Table 4: Global Molecular Diagnostics (MDx) Market by Infectious Diseases Therapeutic Area (2015) - Percentage Share Breakdown by Value Sales for CT/NG, Healthcare-associated Infections (HAI), Hepatitis, HIV, Respiratory and Others......6
Table 5: Global Molecular Diagnostics (MDx) Market by Region (2015) - Percentage Breakdown by Value Sales for Americas, EMEA and Pacific......7
Table 6: Molecular Diagnostic Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Disease Inherited, Infectious Diseases, Oncology, Prenatal, and Tissue Typing......8
Table 7: Molecular Diagnostics (MDx) Market by Location of Test Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Banks, Hospitals, Near-Patient, and Reference Labs......9
Table 8: Molecular Diagnostics (MDx) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Bacteriology, Blood Screening, Genomics and Virology......10
Table 9: Molecular Diagnostics (MDx) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value Sales for Beads, CE Sequencing, Hybrid Capture, ISH, Microarrays, NGS, PCR, Qpcr, TMA, and Others......11
Table 10: Molecular Diagnostics (MDx) Market by Therapeutic Area Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, CT / NG, HAIs, HLA, HPV, Oncology, Viral Load, and Others......12
Table 11: Molecular Diagnostics (MoDx) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Europe, Japan, Korea, US, and Others......13
Table 12: Molecular Diagnostics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Biochip and Lab-on-a-Chip (LOAC), In Situ Hybridization (ISH), Microarrays, Polymerase Chain Reaction (PCR) and Others......14
Table 13: Molecular Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Infectious Diseases, Inherited Disease, Oncology, Prenatal and Tissue Typing......15
Table 14: Molecular Diagnostics Infectious Diseases Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Active Tuberculosis, Blood Banking, Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG), Clostridium difficile, Human Papillomavirus (HPV), Influenza, Panels, S. aureus (SA), and methicillin-resistant S. aureus (MRSA), Viral Load, and Others......16
Table 15: Molecular Diagnostics Test Market by Type in Europe (2015) - Percentage Share Breakdown by Volume for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Methicillin-resistant Staphylococcus aureus (MRSA) and Others......17
Table 16: Spending on Molecular Diagnostics and Genetic Testing by Payer in the US (2015) - Percentage Market Share Breakdown by Value for Cancer, Infectious Diseases, Inhired Conditions and Other......18
Table 17: Molecular Diagnostics Lab Market by Test Complexity in the US (2015) - Percentage Share Breakdown by Volume for Highly Complex w/LDT, Highly Complex, no LDT and Moderately Complex......19
Table 18: Molecular Diagnostics Lab Market by Test Type in the US (2015) - Percentage Share Breakdown by Volume for Both ID & Genetics, Disease, Only and Infectious......20
Table 19: Molecular Diagnostics Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, Genetic Testing Order, Oncology, Virology and Other Infectious Diseases......21
Table 20: Molecular Diagnostic Genetics Laboratories Market by Assay in the US (2015) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis, Epidermal Growth Factor Receptor (EGFR), Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS Gene) and Others......22
Table 21: Number of Molecular Diagnostics Laboratories by CLIA Complexity in the US (2015) - Percentage Market Share Breakdown for Highly Complex, No Laboratory-Developed Test (LDT), Highly Complex, With Laboratory-Developed Test (LDT) and Moderately Complex......23
Table 22: Number of Molecular Diagnostics Laboratories by Testing Type in the US (2015) - Percentage Market Share Breakdown for Genetics Only, Infectious Disease Only and Both Infectious Disease and Genetics......24
Point-Of-Care Diagnostics......25
Table 23: Point-Of-Care Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Blood Gas/Electrolytes, Cardiac, Chemistry, Coagulation, Drugs of Abuse, Fertility/Pregnancy, Infectious Disease, Professional WBG, Urinalysis and Others......25
No. of Hepatitis C Virus (HCV) Patients......26
Table 24: Hepatitis C Virus Market by Patient Conditions in the US (2015) - Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......26
Table 25: Hepatitis C Virus Market by Patient Conditions in Europe (2015) - Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......27
Table 26: No. of Hepatitis C Virus (HCV) Patients by Category in the US (2015) - Percentage Market Share Breakdown for GT1 HCV, GT2/3 HCV, and Others......28
Table 27: No. of Hepatitis C Virus (HCV) Patients by Category in European Union (EU) (2015) - Percentage Market Share Breakdown for GT1, and Non-GT1......29
Table 28: Health Insurance for Hepatitis C Virus (HCV) by Type in the US (2015) - Percentage Market Share Breakdown by Value for Commercial, Dual (Medicare and Medicaid), Medicaid, Medicare (Non- Dual), Prison, Uninsured, and Veteran Affairs......30
Molecular Infectious Disease......31
Table 29: Molecular Infectious Disease Market by Panel Worldwide (2015) - Percentage Share Breakdown by Value Sales for BSI +/- (Sepsis), CSF, Enteric (GI), Fungal (Candida), HCV Genotyping, Respiratory, and STI......31
Rapid Testing Equipment (HIV)......32
Table 30: Market Shares of Leading Rapid Testing Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Alere, Inc. (ALR), Bec World PLC (BEC), Danaher Corporation (DHR), Meridian Bioscience, Inc. (VIVO), OraSure Technologies, Inc. (OSUR), Quidel Corporation (QDEL), and Others......32
Table 31: Market Shares of Leading HIV Rapid Testing Equipment Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Bio-Rad Laboratories, Inc. (BIO), Chembio Diagnostics, Inc. (CEMI), OraSure Technologies, Inc. (OSUR), Trinity Biotech Plc (TRIB), and Others......33
Molecular Infectious Disease Equipment......34
Table 32: Market Shares of Leading Molecular Infectious Disease Diagnostic Equipment Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for BioMeriuex, Bruker Corporation, GenMark Diagnostics, Inc., Luminex Corporation, Nanosphere, Inc., and Others......34
Molecular Diagnostics......35
Table 33: Market Shares of Leading Molecular Diagnostic Product Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, Novartis International AG, Qiagen, and Others......35
Table 34: Market Shares of Leading Molecular Diagnostics (MDx) Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Co., Cepheid, F. Hoffmann-La Roche Ltd., Hologic Gen-Probe, Inc., Novartis AG, Qiagen N.V., Siemens AG and Others......36
Table 35: Market Shares of Leading Molecular Diagnostics (MDx) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., Hologic, Inc., Illumina, Inc., Qiagen N.V., Rogers Corporation, Siemens AG, Thermo Fisher Scientific, and Others......37
Table 36: Chembio Diagnostics, Inc.’s (Operations) Sales by Geographic Region Worldwide (2013-2014) in Percentage for North America, South America, Africa and Other......38
Table 37: Chembio Diagnostics, Inc.’s Sales by Product Segment Worldwide (2013-2014) in Percentage for Lateral Flow HIV Tests and Components, DPP® Tests and Components, R&D, Milestone and Grant Revenue and Others......39